Veracyte
VCYT
222 hedge funds and large institutions have $3.2B invested in Veracyte in 2020 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 68 increasing their positions, 73 reducing their positions, and 23 closing their positions.
148% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 23
80% more call options, than puts
Call options by funds: $5.11M | Put options by funds: $2.84M
55% more capital invested
Capital invested by funds: $2.06B → $3.2B (+$1.14B)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
17% more funds holding
Funds holding: 189 → 222 (+33)
0.16% less ownership
Funds ownership: 113.25% → 113.09% (-0.16%)
7% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 73
Top Buyers
Top Sellers
VCYT Hedge Fund Activity: Q4 2020 in Review
222 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2020, worth a combined $3.2B — up 55% from $2.06B a quarter earlier.
Buyers outnumbered sellers: 57 funds opened new VCYT positions and 23 closed out — a net gain of 34 holders — while 68 added to existing stakes and 73 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $93.1M. The largest seller was Wellington Management Group, cutting an estimated $70M.
- 222 institutional investors held Veracyte (VCYT) as of Q4 2020, up from 189 in Q3 2020.
- Funds reported $3.2B of Veracyte stock for Q4 2020, up 55% quarter-over-quarter.
- 57 funds opened new Veracyte positions in Q4 2020 and 23 closed out, a net change of +34 holders.
- The largest Veracyte buyer in Q4 2020 was ARK Investment Management, an estimated $93.1M added.
- The largest Veracyte seller in Q4 2020 was Wellington Management Group, an estimated $70M sold.
Based on aggregated 13F filings for Q4 2020.